Literature DB >> 9614306

Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters.

D A Andris1, E A Krzywda, C E Edmiston, C J Krepel, C M Gohr.   

Abstract

An in vitro model was designed to evaluate the efficacy of instilled antimicrobials to reduce or eliminate intraluminal microbial colonization. Minimal inhibitory concentration and minimal bactericidal concentration activity of appropriate test anti-infectives were determined using standard methodology against clinically derived and reference test strains commonly associated with catheter-related infection. Drug activity was validated by bioassay for the test anti-infectives. Reference and clinical test strains were inoculated to the intraluminal surface of silicone catheter segments and incubated for 30 min, after which the inoculum was replaced with total parenteral nutrition (TPN) solution and reincubated for 12 h. For 7 d, instillation of antibiotic and TPN solution was alternated every 12 h to simulate clinical conditions. On days 1, 4, and 7, catheter segments were rinsed, bisected, and sonicated for quantitative plate count to determine mean microbial counts per centimeter of catheter surface. Catheter segments were also prepared for scanning electron microscopy. A significant decrease in staphylococcal intraluminal colonization after instillation of nafcillin, ceftriaxone, gentamicin, and vancomycin was demonstrated (P < 0.001). Aztreonam, ceftriaxone, and gentamicin completely eliminated gram-negative catheter colonization (P < 0.001). Yeast was eradicated from the internal catheter surface after treatment with amphoteracin B, and fluconazole significantly decreased intraluminal colonization (P < 0.001). Results show a significant decrease in staphylococcal, gram-negative, and fungal intraluminal colonization after instillation of appropriate antimicrobial. In vitro results support early clinical success using this technique. Future studies are warranted to identify optimal drug concentrations and dosing intervals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614306     DOI: 10.1016/s0899-9007(98)00013-6

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  7 in total

Review 1.  Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition.

Authors:  D Hodge; J W L Puntis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

2.  Comparison of different doses of vancomycin andteicoplanin lock solutions in catheters colonized with Staphylococcus epidermidis: An in vitro, blinded, antibiotic lock study.

Authors:  Serkan Oncu; Serhan Sakarya
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

3.  Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.

Authors:  Matthew K Schinabeck; Lisa A Long; Mohammad A Hossain; Jyotsna Chandra; Pranab K Mukherjee; Sotohy Mohamed; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.

Authors:  T N V Silva; M L Mendes; J M G Abrão; J T Caramori; D Ponce
Journal:  Int Urol Nephrol       Date:  2012-12-27       Impact factor: 2.370

5.  Surface functionalization by covalent immobilization of an innovative carvacrol derivative to avoid fungal biofilm formation.

Authors:  Aïcha Gharbi; Thibaut Legigan; Vincent Humblot; Sébastien Papot; Jean-Marc Berjeaud
Journal:  AMB Express       Date:  2015-02-05       Impact factor: 3.298

Review 6.  Infections in the immunocompromised.

Authors:  Andrew Cant; Theresa Cole
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 7.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.